Superior Group of Companies Reports Third Quarter 2026 Results

Nine-month operating cash generation increased as debt balances declined from year-end 2025.

Rhea-AI Summary

Superior Group of Companies (NASDAQ: SGC) reported third-quarter 2026 sales of $146.0 million, up 5% from a year earlier. Net income fell to $2.6 million from $2.7 million, while diluted earnings per share declined to $0.17 from $0.18. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA), a non-GAAP measure, fell to $6.7 million from $7.5 million.

Branded Products and Contact Centers grew sales, while Healthcare Apparel posted lower sales and an adjusted EBITDA loss. The company raised the lower ends of its 2026 forecasts: sales are expected at $578.0 million–$585.0 million, versus $572.0 million–$585.0 million previously; adjusted diluted earnings per share are expected at $0.60–$0.66, versus $0.54–$0.66. Nine-month operating cash flow rose to $30.679 million from $1.270 million. The company also disclosed its recent acquisition of Select VoiceCom.

17 points · 1 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 10 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.2026 sales forecast tightened to $578.0 million–$585.0 million, from $572.0 million–$585.0 million; 2025 sales were $566.2 million.
• Moderate pointThird-quarter sales rose 5% to $146.0 million from $138.5 million a year earlier.
• Moderate pointBranded Products third-quarter sales increased to $92.111 million from $85.095 million a year earlier.
• Moderate pointBranded Products third-quarter adjusted EBITDA increased to $9.843 million from $7.524 million a year earlier.
• Moderate pointContact Centers third-quarter sales increased to $24.224 million from $22.664 million a year earlier.
• Moderate pointContact Centers third-quarter adjusted EBITDA increased to $2.897 million from $2.373 million a year earlier.
• Moderate pointNine-month sales increased to $434.708 million from $419.609 million a year earlier.
• Moderate pointNine-month net income increased to $4.626 million from $3.537 million a year earlier.
• Moderate pointNine-month adjusted diluted EPS increased to $0.44 from $0.23 a year earlier.
• Moderate pointNine-month operating cash flow increased to $30.679 million from $1.270 million a year earlier.
• Moderate pointLong-term debt declined to $74.287 million from $87.093 million at year-end; its current portion also declined.
• Moderate pointSelect VoiceCom acquisition was recently completed.

5 minor points

• Minor point. Forward-looking: it has not happened yet and may not happen.2026 adjusted diluted EPS forecast tightened to $0.60–$0.66, from $0.54–$0.66, versus $0.46 in 2025.
• Minor pointNine-month diluted EPS increased to $0.31 from $0.23 a year earlier.
• Minor pointCash increased to $27.924 million at September 30, 2026, from $23.691 million at year-end 2025.
• Minor pointNet third-quarter interest expense fell to $0.809 million from $1.378 million a year earlier.
• Minor point. Forward-looking: it has not happened yet and may not happen.Healthcare Apparel plans a more focused product strategy to improve margins and reduce working capital requirements.

Negative

• Moderate pointThird-quarter adjusted EBITDA declined to $6.7 million from $7.5 million a year earlier.
• Moderate pointHealthcare Apparel third-quarter adjusted EBITDA swung to a $0.501 million loss from a $3.179 million profit.
• Moderate pointNine-month inventory write-downs increased to $9.498 million from $1.793 million a year earlier. 4.4% of market cap
• Moderate pointThird-quarter selling and administrative expenses increased to $51.866 million from $48.513 million a year earlier.
• Minor pointThird-quarter net income declined to $2.6 million from $2.7 million a year earlier.

5 minor points

• Minor pointThird-quarter diluted EPS declined to $0.17 from $0.18 a year earlier.
• Minor pointHealthcare Apparel third-quarter sales fell to $30.553 million from $31.520 million a year earlier.
• Minor pointHealthcare Apparel recorded a nine-month $0.435 million adjusted EBITDA loss.
• Minor pointHealthcare Apparel incurred a nine-month $2.600 million trade name impairment charge.
• Minor pointNine-month credit loss expense increased to $3.165 million from $2.347 million a year earlier.

News Explained

At September 30, 2026, SGC reported $27,924 thousand in cash and cash equivalents, alongside $3,750 thousand of current debt and $74,287 thousand of long-term debt.

Key Figures

Q3 net sales: $146.0 million, up 5% Q3 net income: $2.6 million Q3 adjusted EBITDA: $6.7 million +2 more

Q3 net sales

$146.0 million, up 5%

Third quarter 2026 versus prior-year quarter

Q3 net income

$2.6 million

Versus $2.7 million in the prior-year quarter

Q3 adjusted EBITDA

$6.7 million

Versus $7.5 million in the prior-year quarter

2026 net sales outlook

$578.0 million to $585.0 million

Tightened from the previous $572.0 million to $585.0 million range

2026 adjusted earnings per diluted share outlook

$0.60 to $0.66

Tightened from the previous $0.54 to $0.66 range

Previous Earnings Reports

1 past event · Latest: Aug 04

Same Type 1 event

1. Aug 04

   Quarterly earnings

   24h Move

   +8.0%

   Q2 sales rose, and the company reaffirmed its 2026 sales and adjusted-EPS ranges.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

adjusted ebitda, non-gaap

2 terms

adjusted ebitda financial

"Adjusted EBITDA of $6.7 million versus $7.5 million in prior year third quarter"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial

"Adjusted net income and diluted adjusted net income per share, which are non-GAAP measures"

Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Total net sales of $146.0 million, up 5% over prior year third quarter

• Net income of $2.6 million versus $2.7 million in prior year third quarter

• Adjusted EBITDA of $6.7 million versus $7.5 million in prior year third quarter

• Tightens full-year Outlook

ST. PETERSBURG, Fla., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its third quarter 2026 results.

“We drove solid overall top line growth from continued momentum in our Branded Products and Contact Centers segments,” said Michael Benstock, Chief Executive Officer. “New leadership in Healthcare Apparel continues to execute toward a more focused product strategy to improve margins and reduce working capital requirements in the quarters ahead. On a consolidated basis, we were able to hold EPS essentially flat versus the prior year quarter despite incremental charges associated with our strategic shift in Healthcare Apparel. We look forward to finishing the year with growth in both sales and earnings compared to 2025, and with a solid balance sheet that provides the foundation for continued strategic investment such as our recent acquisition of Select VoiceCom and the return of capital to shareholders.”

Third Quarter Results

For the third quarter ended September 30, 2026, net sales were $146.0 million, up 5% from third quarter 2025 net sales of $138.5 million. Net income was $2.6 million or $0.17 per diluted share compared to net income of $2.7 million or $0.18 per diluted share for the third quarter of 2025.

2026 Full-Year Outlook

The Company tightened its full-year 2026 net sales forecast to a range of $578.0 million to $585.0 million, from its previous range of $572.0 million to $585.0 million, up from 2025 net sales of $566.2 million. It also tightened its full-year adjusted earnings per diluted share forecast to a range of $0.60 to $0.66, from its previous range of $0.54 to $0.66, up from $0.46 in 2025 and representing 43% growth at the high end.

Webcast and Conference Call

The Company will host a webcast and conference call at 8:00am Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for international dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through November 23, 2026. To access the replay, dial 1-855-669-9658 in the United States or Canada, or 1-412-317-0088 from international locations. Please reference conference number 8522694 for replay access.

Disclosure Regarding Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release include 2026 guidance of net sales and earnings per diluted share and may also include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the impact of global conflicts, such as the Russia-Ukraine War and the joint U.S.-Israeli War with Iran in 2026, oil and natural gas prices, uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (“U.S.” or “United States”) in which the Company’s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the Company's ability to maintain effective internal control over financial reporting; and other factors described in the Company’s filings with the Securities and Exchange Commission ("SEC"), including those risks described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled "Risk Factors" and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About Superior Group of Companies, Inc. (SGC):

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Investor Relations Contact: 
Investors@Superiorgroupofcompanies.com

    

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except shares and per share data)
	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Net sales	$	145,994			$	138,467			$	434,708			$	419,609
Costs and expenses:
Cost of goods sold		90,168				85,389				270,429				260,764
Selling and administrative expenses		51,866				48,513				153,561				150,855
Interest expense, net		809				1,378				2,702				3,873
Trade name impairment charge		-				-				2,600				-
		142,843				135,280				429,292				415,492
Income before income tax expense		3,151				3,187				5,416				4,117
Income tax expense		580				443				790				580
Net income	$	2,571			$	2,744			$	4,626			$	3,537
Net income per share:
Basic	$	0.17			$	0.19			$	0.32			$	0.24
Diluted	$	0.17			$	0.18			$	0.31			$	0.23
Weighted average shares outstanding during the period:
Basic		14,787,455				14,738,863				14,637,206				15,050,834
Diluted		15,247,892				15,119,050				15,024,519				15,422,144
Cash dividends per common share	$	0.14			$	0.14			$	0.42			$	0.42

   

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In thousands, except shares and par value data)
	September 30,				December 31,
	2026				2025
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	27,924			$	23,691
Accounts receivable, net		96,273				104,336
Inventories		87,936				97,474
Contract assets		52,860				48,903
Prepaid expenses and other current assets		16,741				13,259
Total current assets		281,734				287,663
Property, plant and equipment, net		34,250				37,352
Operating lease right-of-use assets		11,258				12,620
Deferred tax asset		14,954				15,003
Intangible assets, net		42,051				47,254
Goodwill		2,583				2,583
Other assets		21,009				19,369
Total assets	$	407,839			$	421,844
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	51,325			$	48,343
Other current liabilities		52,222				53,041
Current portion of long-term debt		3,750				6,563
Current portion of acquisition-related contingent liabilities		682				-
Total current liabilities		107,979				107,947
Long-term debt		74,287				87,093
Long-term pension liability		15,233				15,010
Long-term acquisition-related contingent liabilities		455				826
Long-term operating lease liabilities		6,630				7,939
Other long-term liabilities		10,217				10,211
Total liabilities		214,801				229,026
Shareholders’ equity:
Preferred stock, $0.001 par value - authorized 300,000 shares (none issued)		-				-
Common stock, $0.001 par value - authorized 50,000,000 shares, issued and outstanding 15,894,450 and 15,730,615 shares, respectively		16				16
Additional paid-in capital		86,088				84,628
Retained earnings		110,169				112,871
Accumulated other comprehensive loss, net of tax		(3,235	)			(4,697	)
Total shareholders’ equity		193,038				192,818
Total liabilities and shareholders’ equity	$	407,839			$	421,844

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands)
	Nine Months Ended September 30,
	2026				2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	4,626			$	3,537
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		8,489				9,157
Inventory write-downs		9,498				1,793
Credit loss expense		3,165				2,347
Share-based compensation expense		2,523				3,916
Trade name impairment charge		2,600				-
Change in fair value of acquisition-related contingent liabilities		311				659
Non-cash operating lease expense		3,116				2,843
Other, net		183				244
Changes in assets and liabilities:
Accounts receivable		5,338				(3,710	)
Contract assets		(3,920	)			3,326
Inventories		91				(10,535	)
Prepaid expenses and other current assets		(2,963	)			(423	)
Other assets		(1,778	)			(1,692	)
Accounts payable and other current liabilities		(1,432	)			(10,636	)
Payment of acquisition-related contingent liabilities		-				(791	)
Other long-term liabilities		832				1,235
Net cash provided by operating activities		30,679				1,270
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment		(2,675	)			(3,407	)
Net cash used in investing activities		(2,675	)			(3,407	)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under revolving lines of credit		33,545				76,000
Payments under revolving lines of credit		(63,545	)			(58,000	)
Borrowings under term loan		24,375				-
Payments of term loan		(9,375	)			(4,218	)
Debt issuance costs		(821	)			-
Payments of cash dividends		(6,575	)			(6,713	)
Payment of acquisition-related contingent liabilities		-				(226	)
Shares withheld for taxes net of proceeds received on exercise of stock options		(351	)			90
Common shares repurchased and retired		(1,465	)			(7,928	)
Net cash used in financing activities		(24,212	)			(995	)
Effect of currency exchange rates on cash		441				1,017
Net increases (decreases) in cash and cash equivalents		4,233				(2,115	)
Cash and cash equivalents balance, beginning of period		23,691				18,766
Cash and cash equivalents balance, end of period	$	27,924			$	16,651

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES ADJUSTED NET INCOME & NON-GAAP RECONCILIATION (Unaudited) (In thousands)

​

Three Months Ended September 30,

​

​

Nine Months Ended September 30,

​

​

2026

​

​

2025

​

​

2026

​

​

2025

​

Net income

$

2,571

​

​

$

2,744

​

​

$

4,626

​

​

$

3,537

​

Add backs:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Trade name impairment charge

​

-

​

​

​

-

​

​

​

2,600

​

​

​

-

​

Tax impact of adjustments(1)

​

-

​

​

​

-

​

​

​

(640

)

​

​

-

​

Adjusted net income(2)

$

2,571

​

​

$

2,744

​

​

$

6,586

​

​

$

3,537

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted net income per share

$

0.17

​

​

$

0.18

​

​

$

0.31

​

​

$

0.23

​

Add back items, after-tax, per diluted share

​

-

​

​

​

-

​

​

​

0.13

​

​

​

-

​

Diluted adjusted net income per share(2)

$

0.17

​

​

$

0.18

​

​

$

0.44

​

​

$

0.23

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average shares outstanding during the period:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted, as reported and adjusted

​

15,247,892

​

​

​

15,119,050

​

​

​

15,024,519

​

​

​

15,422,144

​

⁽¹⁾ The tax impact of adjustments includes the tax effect of each separate adjustment based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible, and the tax effect of items that relate to tax specific financial transactions.
⁽²⁾ Adjusted net income and diluted adjusted net income per share, which are non-GAAP measures, are defined as net income (loss) and net income (loss) per share, excluding the impacts of impairment and pension plan termination charges. Management believes adjusted net income (loss) and diluted adjusted net income (loss) per share provides useful information to investors because it allows management, investors and others to evaluate and compare our operating results from period to period by removing the impact of impairment and pension plan termination charges that are not reflective of our core business. Adjusted net income and Diluted adjusted net income per share should not be considered in isolation or as an alternative to net income or net income per share or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted net income and Diluted adjusted net income per share are significant components in understanding and assessing the Company’s net income. The Company’s Adjusted net income and Diluted adjusted net income per share may not be comparable to a similarly titled measure of another company because other companies may not calculate Adjusted net income and Diluted adjusted net income per share in the same manner.

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS & NON-GAAP RECONCILIATIONS (Unaudited) (In thousands)
	Branded Products				Healthcare Apparel				Contact Centers				Intersegment Eliminations				Total
For the Three Months Ended September 30, 2026:
Net sales	$	92,111			$	30,553			$	24,224			$	(894	)		$	145,994
Cost of goods sold		58,602				20,575				11,398				(407	)			90,168
Gross margin		33,509				9,978				12,826				(487	)			55,826
Less: Selling and administrative expenses		24,961				11,303				10,496				(487	)			46,273
Less: Trade name impairment charge		-				-				-				-				-
Add backs:
Trade name impairment charge		-				-				-				-				-
Segment depreciation and amortization		1,295				824				567				-				2,686
Segment Adjusted EBITDA(4)	$	9,843			$	(501	)		$	2,897			$	-			$	12,239
Less corporate selling and administrative expenses																		5,593
Add back corporate depreciation and amortization																		61
Adjusted EBITDA(3)																	$	6,707
	Branded Products				Healthcare Apparel				Contact Centers				Intersegment Eliminations				Total
For the Three Months Ended September 30, 2025:
Net sales	$	85,095			$	31,520			$	22,664			$	(812	)		$	138,467
Cost of goods sold		55,466				19,394				10,669				(140	)			85,389
Gross margin		29,629				12,126				11,995				(672	)			53,078
Less: Selling and administrative expenses		23,501				9,779				10,283				(672	)			42,891
Add backs:
Segment depreciation and amortization		1,396				832				661				-				2,889
Segment Adjusted EBITDA(4)	$	7,524			$	3,179			$	2,373			$	-			$	13,076
Less corporate selling and administrative expenses																		5,622
Add back corporate depreciation and amortization																		86
Adjusted EBITDA(3)																	$	7,540

	Branded Products				Healthcare Apparel				Contact Centers				Intersegment Eliminations				Total
For the Nine Months Ended September 30, 2026:
Net sales	$	281,370			$	86,385			$	69,571			$	(2,618	)		$	434,708
Cost of goods sold		181,002				57,259				33,381				(1,213	)			270,429
Gross margin		100,368				29,126				36,190				(1,405	)			164,279
Less: Selling and administrative expenses		75,708				32,027				30,413				(1,405	)			136,743
Less: Trade name impairment charge		-				2,600				-				-				2,600
Add backs:
Trade name impairment charge		-				2,600				-				-				2,600
Segment depreciation and amortization		4,013				2,466				1,804				-				8,283
Segment Adjusted EBITDA(4)	$	28,673			$	(435	)		$	7,581			$	-			$	35,819
Less corporate selling and administrative expenses																		16,818
Add back corporate depreciation and amortization																		206
Adjusted EBITDA(3)																	$	19,207
	Branded Products				Healthcare Apparel				Contact Centers				Intersegment Eliminations				Total
For the Nine Months Ended September 30, 2025:
Net sales	$	264,216			$	87,036			$	70,866			$	(2,509	)		$	419,609
Cost of goods sold		173,884				54,761				33,277				(1,158	)			260,764
Gross margin		90,332				32,275				37,589				(1,351	)			158,845
Less: Selling and administrative expenses		72,353				29,383				32,816				(1,351	)			133,201
Add backs:
Segment depreciation and amortization		4,271				2,598				2,022				-				8,891
Segment Adjusted EBITDA(4)	$	22,250			$	5,490			$	6,795			$	-			$	34,535
Less corporate selling and administrative expenses																		17,654
Add back corporate depreciation and amortization																		266
Adjusted EBITDA(3)																	$	17,147

The following table reconciles income before income tax expense to Total Segment Adjusted EBITDA (in thousands):

	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Income before income tax expense	$	3,151			$	3,187			$	5,416			$	4,117
Interest expense, net		809				1,378				2,702				3,873
Corporate selling and administrative expenses		5,593				5,622				16,818				17,654
Segment depreciation and amortization		2,686				2,889				8,283				8,891
Trade name impairment charge		-				-				2,600				-
Total Segment Adjusted EBITDA	$	12,239			$	13,076			$	35,819			$	34,535

The following table reconciles net income to Adjusted EBITDA (in thousands):

	Three Months Ended September 30,								Nine Months Ended September 30,
	2026				2025				2026				2025
Net income	$	2,571			$	2,744			$	4,626			$	3,537
Interest expense, net		809				1,378				2,702				3,873
Income tax expense		580				443				790				580
Segment depreciation and amortization		2,686				2,889				8,283				8,891
Corporate depreciation and amortization		61				86				206				266
Trade name impairment charge		-				-				2,600				-
Adjusted EBITDA(3)	$	6,707			$	7,540			$	19,207			$	17,147
Adjusted EBITDA margin(3)		4.6	%			5.4	%			4.4	%			4.1	%

⁽³⁾ Adjusted EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense, impairments and depreciation and amortization expense. Adjusted EBITDA margin is defined as Adjusted EBITDA divided by net sales. The Company believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences, (iii) asset base (depreciation and amortization) and (iv) impairments. The Company uses Adjusted EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used Adjusted EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. Adjusted EBITDA is not a measure of financial performance under GAAP.  Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s Adjusted EBITDA may not be comparable to a similarly titled measure of another company because other companies may not calculate Adjusted EBITDA in the same manner.
⁽⁴⁾ Segment Adjusted EBITDA, as reported above for each segment, is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, net, impairments and depreciation and amortization expense. Total Segment Adjusted EBITDA is a non-GAAP financial measure and is reconciled to its most closely comparable GAAP metric of income before income tax expense in the table above. 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Superior Group of Companies' third-quarter 2026 earnings?

Superior Group of Companies earned $2.6 million, or $0.17 per diluted share, in the quarter ended September 30, 2026. That compares with $2.7 million, or $0.18 per diluted share, a year earlier. Sales increased 5% to $146.0 million.

What is SGC's updated full-year 2026 outlook?

SGC expects $578.0 million–$585.0 million in sales and $0.60–$0.66 in adjusted diluted earnings per share for 2026. The previous ranges were $572.0 million–$585.0 million and $0.54–$0.66, respectively, so both lower bounds increased while the upper bounds remained unchanged.